🇺🇸 FDA
Patent

US 9095612

Halogenated compounds for photodynamic therapy

granted A61KA61K31/403A61K31/404

Quick answer

US patent 9095612 (Halogenated compounds for photodynamic therapy) held by NANOQUANTUM SCIENCES, INC. expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
NANOQUANTUM SCIENCES, INC.
Grant date
Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/403, A61K31/404, A61K31/438, A61K41/0057